Literature DB >> 25304295

Relationship between TG/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population.

Chih-I Ho1, Jau-Yuan Chen1, Shou-Yen Chen2, Yi-Wen Tsai1, Yi-Ming Weng2, Yu-Chung Tsao3, Wen-Cheng Li4.   

Abstract

BACKGROUND & AIMS: The triglycerides-to-high-density lipoprotein-cholesterol (TG/HDL-C) ratio has been identified as a biomarker of insulin resistance and a predictor for atherosclerosis. The objectives of this study were to investigate which the TG/HDL-C ratio is useful to detect metabolic syndrome (MS) risk factors and subclinical chronic kidney disease (CKD) in general population without known CKD or renal impairment and to compare predictive accuracy of MS risk factors.
METHODS: This was a cross-sectional study. A total 46,255 subjects aged ≥18 years undergoing health examination during 2010-2011 in Taiwan. The independent associations between TG/HDL-C ratio quartiles, waist circumstance (WC) waist-to-height ratio (WHtR), mean atrial pressure (MAP), and CKD prevalence was analyzed by using logistic regression models. Analyses of the areas under receiver operating characteristic (ROC) were performed to determine the accuracy of MS risk factors in predicting CKD.
RESULTS: A dose-response manner was observed for the prevalence of CKD and measurements of MS risk factors, showing increases from the lowest to the highest quartile of the TG/HDL-C ratio. Males and females in the highest TG/HDL-C ratio quartile (>2.76) had a 1.4-fold and 1.74-fold greater risk of CKD than those in the lowest quartile (≤1.04), independent of confounding factors. Mean arterial pressure (MAP) had the highest AUC for predicting CKD among MS risk factors. The TG/HDL-C ratio was an independent risk factor for CKD, but it showed no superiority over MAP in predicting CKD. A TG/HDL-C ratio ≥2.76 may be useful in clinical practice to detect subjects with worsened cardiometabolic profile who need monitoring to prevent CKD.
CONCLUSIONS: TG/HDL-C ratio is an independent risk factor for CKD in adults aged 18-50 years. MAP was the most powerful predictor over other MS risk factors in predicting CKD. However, longitudinal and comparative studies are required to demonstrate the predictive value of TG/HDL-C on the onset and progression of CKD over time.
Copyright © 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Mean arterial pressure; Metabolic syndrome risk factor; TG/HDL-C ratio; eGFR

Mesh:

Substances:

Year:  2014        PMID: 25304295     DOI: 10.1016/j.clnu.2014.09.007

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  12 in total

Review 1.  Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.

Authors:  Judy Baek; Chenchen He; Farsad Afshinnia; George Michailidis; Subramaniam Pennathur
Journal:  Nat Rev Nephrol       Date:  2021-10-06       Impact factor: 42.439

2.  Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin.

Authors:  C Santangelo; C Filesi; R Varì; B Scazzocchio; T Filardi; V Fogliano; M D'Archivio; C Giovannini; A Lenzi; S Morano; R Masella
Journal:  J Endocrinol Invest       Date:  2016-06-25       Impact factor: 4.256

3.  Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China.

Authors:  Xin-Yao Liu; Qiao-Yu Wu; Zhi-Heng Chen; Guang-Yu Yan; Yao Lu; Hai-Jiang Dai; Ying Li; Ping-Ting Yang; Hong Yuan
Journal:  Endocrine       Date:  2020-01-15       Impact factor: 3.633

4.  Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5-year period.

Authors:  Gang Li; Hui-Kun Wu; Xiao-Wei Wu; Zhe Cao; Yuan-Chao Tu; Yi Ma; Wei-Qing Wang; Jian Cheng; Zi-Hua Zhou
Journal:  Lipids Health Dis       Date:  2018-02-12       Impact factor: 3.876

5.  25-hydroxyvitamin D levels are inversely related to metabolic syndrome risk profile in northern Chinese subjects without vitamin D supplementation.

Authors:  Hanyuan Xu; Guiyan Han; Linjie Wang; Huihua Ding; Chunyan Wang; Xiaochuan Ping; Caixia Dong; Dianxi Zhang; Yufei Dai; Naishi Li; Yufeng Li; Hongbo Yang; Huijuan Zhu; Hui Pan; Fengying Gong; Jichun Chen; Xiaoping Xing
Journal:  Diabetol Metab Syndr       Date:  2022-01-29       Impact factor: 3.320

6.  Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study.

Authors:  Leonardo De Luca; Pier Luigi Temporelli; Furio Colivicchi; Lucio Gonzini; Maria Luisa Fasano; Massimo Pantaleoni; Gabriella Greco; Fabrizio Oliva; Domenico Gabrielli; Michele Massimo Gulizia
Journal:  Front Cardiovasc Med       Date:  2022-04-13

7.  TG/HDL-C Ratio Is a Risk Factor Associated with CKD: Use in Assessing the Risk of Progression of CKD.

Authors:  Ha Hong Nguyen; Ha Hai Tran; Le Thi Nguyen; Thang Nguyen; Nhut Anh Nguyen; Mai Tuyet Vi; Kien Trung Nguyen
Journal:  Pathophysiology       Date:  2022-07-17

8.  Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients.

Authors:  Wenkai Xia; Xiajuan Yao; Yan Chen; Jie Lin; Volker Vielhauer; Hong Hu
Journal:  BMC Nephrol       Date:  2020-08-03       Impact factor: 2.388

9.  Value of reduced glomerular filtration rate assessment with cardiometabolic index: insights from a population-based Chinese cohort.

Authors:  Hao-Yu Wang; Wen-Rui Shi; Xin Yi; Shu-Ze Wang; Si-Yuan Luan; Ying-Xian Sun
Journal:  BMC Nephrol       Date:  2018-10-25       Impact factor: 2.388

10.  Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China.

Authors:  Xin Wang; Haishan Chen; Xiaofei Shao; Chongxiang Xiong; Guobao Hong; Jianhui Chen; Xiaolin Li; Xu You; Peichun Gao; Yunying Chen; Ziliang Zou; Jing Ning; Hua Xiao; Hequn Zou; Lixin Wei
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-04       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.